GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with GC4711 in the treatment of unresectable or borderline resectable nonmetastatic pancreatic cancer (PC).

Sarah E. Hoffe,Dae Won Kim,James C. Costello,Mokenge P. Malafa,Todd A. Aguilera,Muhammad Shaalan Beg,Parag J. Parikh,Joseph M. Herman,Jon Holmlund,Kara Terry,Elizabeth C. Moser

GRECO-2: A randomized, phase 2 study of stereotactic body radiation therapy (SBRT) in combination with GC4711 in the treatment of unresectable or borderline resectable nonmetastatic pancreatic cancer (PC).

2021

Sarah E. Hoffe
Dae Won Kim
James C. Costello
Mokenge P. Malafa
Todd A. Aguilera
Muhammad Shaalan Beg
Parag J. Parikh
Joseph M. Herman
Jon Holmlund
Kara Terry
Elizabeth C. Moser

TPS4175Background: While systemic treatment of PC has improved, rates of surgical resection - considered optimum treatment - remain low. Patients with un-resectable or borderline PC still have poor...

Keywords:

Radiology
surgical resection
borderline resectable
Medicine
Pancreatic cancer
stereotactic body radiation therapy
Phases of clinical research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations